Artal Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Artal Group’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-500,000	Closed	-$8.47M	–	103
2014 Q4	$8.47M	Sell	500,000 -500,000	-50%	-$7.03M	0.3%	54
2014 Q3	$11.9M	Hold	1,000,000	–	–	0.44%	40
2014 Q2	$5.64M	Sell	1,000,000 -300,000	-23%	-$1.38M	0.23%	60
2014 Q1	$4.77M	Buy	1,300,000 +200,000	+18%	+$762K	0.17%	72
2013 Q4	$3.7M	Buy	1,100,000 +800,000	+267%	+$3.3M	0.13%	67
2013 Q3	$1.27M	Sell	300,000 -500,000	-63%	-$2.37M	0.04%	78
2013 Q2	$3.68M	Buy	+800,000	New	+$2.75M	0.12%	79

Artal Group's AVNR Position: Q4 2014 in Review

Artal Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 2,000,000 shares — an estimated $28.1M sold.

Artal Group first reported a position in AVNR in Q2 2013 and held it in 6 quarters. The position peaked at $23.8M in Q3 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

Artal Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
Artal Group sold 2,000,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $28.1M.
Artal Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 6 quarters.
Artal Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $23.8M in Q3 2014.
166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Artal Group's 13F filing for Q4 2014, filed 13 Feb 2015.